Andrew J. Roth

Nurses and oncologists need to give portal vein thrombosis a closer look, according to one oncolgy nurse.

A team approach to treatment could improve outcomes for patients with head and neck cancer.

This new study set out to evaluate the mortality differences between married and unmarried individuals.

O’Shaughnessy highlighted a group of agents that encompasses entirely new ideas and new options for patients as well as novel avenues from follow-up data from clinical trials.

The treatment landscape of chronic lymphocytic leukemia is rapidly evolving, according to Jeffrey Jones, an assistant professor at The Ohio State University Comprehensive Cancer Center.

In the midst of the approval of new treatments for colorectal cancer, Alan P. Venook wants to remind health care professionals not to forget the more traditional and established therapies.

CURE speaks with Joyce O’Shaughnessy, MD, on the rise of treatment options for patients with estrogen receptor (ER)-positive metastatic breast cancer.

High-quality wigs can put a financial burden on patients with cancer. Lolly's Locks wants to help.

A Missouri jury has ordered Johnson & Johnson to pay $72 million in damages to the family of a woman who died from ovarian cancer, which she said was caused by products containing talcum powder.

"The overuse of emergency rooms is driving up health care costs and can hurt the quality of patient care in many ways," said Gregory Masters.

Hall of Fame quarterback Bob Griese lost his first wife and numerous friends to cancer. Now, he’s using his celebrity to help raise awareness and funds.

Held each year on Feb. 4, World Cancer Day aims to unite people from around the world to increase awareness of cancer in a positive and inspiring way.

To gain insight into the methodology and impacts of this research, CURE interviewed Joan H. Schiller, an author on the study.

Shannon Kerr isn't shy about proclaiming her status as a cancer survivor. At the 2016 Battlefrog Fiesta Bowl in Phoenix, Kerr was joined by a stadium full of fans in drawing attention to the disease and the toll it can take.

CURE sat down with Smita Bhatia to discuss her lecture and key issues in cancer survivorship.

Interim results from the study of 26 individuals were presented by Danielle Novetsky Friedman at the 2016 Cancer Survivorship Symposium held in San Francisco.

"Low-income women tend to have less access to high-quality health care, along with unique needs and concerns," says Rose C. Maly.

To gain insight into the research needed in glioblastoma, we interviewed Robert M. Prins, an associate professor in residence at UCLA.

Former U.S. president Jimmy Carter once again provided an update on his health today.

Though clinical work is ongoing and early, researchers are already considering how to manage potentially fatal neurotoxicities in patients treated with chimeric antigen receptor (CAR) T-cell therapy.

To gain insight into the recent flurry of FDA approvals in melanoma, CURE spoke with Tim Turnham, the executive director of the Melanoma Research Foundation.

Based on this study, the monoclonal antibody is being investigated in an ongoing phase 3 study and has received an FDA Breakthrough Therapy Designation.

XRAYS aims to be "a reliable resource designed to help young breast cancer survivors and high-risk women navigate through breast cancer research related news and information."

To gain insight into the updated ACS breast screening guidelines, CURE spoke with our editor-in-chief, Debu Tripathy.

A novel service model allowed for shorter durations of treatment with radiation, fewer unfinished treatments with radiation, shorter hospital stays and increased use of palliative care.

To gain a patient's perspective on the Genomics of Young Lung Cancer Study and the importance of genomic testing, we spoke with Corey Wood, a 23-year-old trial participant and lung cancer survivor.

Former U.S. president Jimmy Carter provided an update on his health today in a press conference, announcing that he has melanoma.

CURE sat down with Suresh S. Ramalingam to discuss important considerations for patients, caregivers, nurses and physicians when treatment with an immunotherapy begins.